Anca-associated Vasculitis
📧 Sign up to get email alerts when something new happens for Anca-associated Vasculitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: PR3-AAV Resilient Remission or PRRR [Phase 2]
A Phase 2 trial of PR3-AAV Resilient Remission (PRRR) for ANCA-associated vasculitis, including granulomatosis with polyangiitis and microsc…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Hydroxychloroquine in ANCA Vasculitis Evaluation [Phase 4]
Phase 4 trial update evaluating hydroxychloroquine for ANCA-associated vasculitis, including microscopic polyangiitis, eosinophilic granulom…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis
A clinical trial is examining subclinical cytomegalovirus reactivation in patients with acute ANCA-associated vasculitis. The study status i…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis
A clinical trial is recruiting to investigate neutrophil extracellular traps in systemic sclerosis and related connective tissue diseases, s…
-
FDA approval · 2024-06-03FDA Approved: TAVNEOS — Supplemental Application (ChemoCentryx, Inc.)
The FDA approved a supplemental application for TAVNEOS (avacopan) submitted by ChemoCentryx, expanding its regulatory status for the treatm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
This clinical trial update covers the safety and potential efficacy of anti-CD19 CAR-T cells for relapsed/refractory autoimmune diseases, wi…
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis [Phase 3]
A Phase 3 clinical trial update exploring rituximab for durable remission in ANCA-associated vasculitis.
-
CLINICAL_TRIALS trial_result · 2023-08-16Clinical Trial Update: Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis [Phase 2]
Phase 2 trial evaluating CCX168 for ANCA-associated vasculitis has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM) [Phase 4]
Phase 4 trial update evaluating efficacy and safety of telitacicept as maintenance treatment for ANCA-associated vasculitis in remission.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM) [Phase 4]
Phase 4 trial update exploring rituximab combined with telitacicept for ANCA-associated vasculitis, focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis [Phase 3]
Phase 3 trial of avacopan (CCX168) in ANCA-associated vasculitis has completed, with results posted.
-
FDA approval · 2022-07-06FDA Approved: TAVNEOS — Supplemental Application (ChemoCentryx, Inc.)
The FDA approved a supplemental application for TAVNEOS (avacopan) submitted by ChemoCentryx, Inc.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Rituximab and Belimumab Combination Therapy in PR3 Vasculitis [Phase 2]
A Phase 2 trial evaluating Rituximab and Belimumab combination therapy for ANCA-associated vasculitis, including granulomatosis with polyang…
-
FDA approval · 2021-10-07FDA Approved: TAVNEOS — Original Application (ChemoCentryx, Inc.)
FDA approved Tavneos (avacopan) from ChemoCentryx for adults with ANCA-associated vasculitis, in combination with standard therapy, includin…
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis [Phase 2]
Phase 2 study of avacopan (CCX168) in ANCA-associated vasculitis has completed and results have been posted.
-
CLINICAL_TRIALS research · 2018-05-03Clinical Trial Update: Acquired Immunodeficiency in ANCA Associated Vasculitis [Phase 2]
This clinical trial update notes a Phase 2 study on acquired immunodeficiency in ANCA-associated vasculitis; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: The ANCA Vasculitis Questionnaire (AAV-PRO©)
The ANCA Vasculitis Questionnaire (AAV-PRO©) trial update notes that the study evaluating a patient-reported outcome instrument for ANCA-ass…
-
CLINICAL_TRIALS research · 2016-11-30Clinical Trial Update: CMV Modulation of the Immune System in ANCA-associated Vasculitis [Phase 2]
This update covers a Phase 2 trial investigating CMV modulation of the immune system in ANCA-associated vasculitis. The current trial status…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis
This clinical trial update reports on residual anti-pneumococcal immunity following pneumococcal vaccination in patients with ANCA-associate…
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)
The ANCA-associated vasculitis immune tolerance trial sponsored by NIAID was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis
This clinical trial update reports on the immunogenicity of a combined anti-pneumococcal vaccine schedule in patients with ANCA-associated v…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Abatacept in ANCA Associated Vasculitis [Phase 2]
A Phase 2 trial evaluating abatacept for ANCA-associated vasculitis has been terminated.
-
CLINICAL_TRIALS research · 2014-04-29Clinical Trial Update: Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis
An observational study update on pulmonary vasculitis in Chinese patients, describing clinical manifestations and outcomes across ANCA-assoc…
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis [Phase 2, Phase 3]
This entry notes a completed Phase 2/3 clinical trial comparing mycophenolate mofetil with cyclophosphamide in ANCA-associated vasculitis.
-
CLINICAL_TRIALS research · 2010-11-10Clinical Trial Update: Clinical Relevance of Anti-Neutrophil Cytoplasm Antibody (ANCA)in Hospitalized Patients
An update on a clinical trial examining the clinical relevance of anti-neutrophil cytoplasm antibodies (ANCA) in hospitalized patients with …